Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Conversion Therapy topic
No spam. Unsubscribe anytime.
House panel amends conversion-therapy bill to clarify consent and parental involvement; passes 8-4-1
Summary
The House Human Services Committee amended House Bill 14-30 to refine the bill’s definition of conversion therapy and to add a parental-notification clause in one subsection before voting to send the bill forward as amended.
The House Human Services Committee on an unspecified date amended and advanced House Bill 14-30, a bill addressing “conversion therapy,” after extended discussion about consent, parental notification and provider confidentiality.
Lawmakers narrowed the bill’s language to define conversion therapy as “any treatment intended to change an individual's sexual orientation or gender identity without their knowledge and consent” and later adopted an amendment that reinstated language requiring that an individual's parent or guardian be included under a specific condition of engagement in treatment. Representative Polly introduced the drafting changes and discussed the sponsor-suggested text; Representative Balinski moved the specific change to restore parental or guardian inclusion in subsection C.
Supporters and critics debated how the bill would interact with existing privacy and mandatory-reporting rules. Several committee members asked whether the statutory language would inadvertently create a loophole that allowed minors to receive treatment without parental consent. Committee members and witnesses referenced HIPAA and mandatory reporting as constraints on how providers share information with parents. Representative Dobrevitch and others described standard clinical practice as including initial parental consent in many outpatient settings while recognizing circumstances (for example, suspected abuse or court-ordered treatment) that change how and when information is disclosed.
During discussion Representative Freilich and others sought assurance that the bill would not allow medical or therapeutic procedures for minors without parental authorization. Committee members repeatedly emphasized that current clinical and legal guardrails — including mandated reporting requirements and HIPAA protections — govern when providers must inform parents and when confidentiality applies.
On the amendment to add parental or guardian language to subsection C, the committee voted 8-4-0 in favor. The committee then voted to give the bill a “do pass as amended” recommendation; the roll call for the due-pass motion recorded the outcome as 8 yes, 4 no, 1 absent.
The committee discussion repeatedly distinguished between (1) initial consent or authorization for treatment, which several members said normally involves the parent or guardian for minors, and (2) patient-provider confidentiality during ongoing therapeutic sessions, which committee members said may limit the details providers can share without a court order or other legal basis.
The committee did not adopt further procedural changes beyond the recorded amendments. The bill will proceed with the committee’s recommendation and the adopted text that includes the clarified definition and the restored parental/guardian reference in subsection C.
The bill’s sponsors and committee members indicated they expect further review on the floor and possibly additional amendments later in the process.
